XKRX
216080
Market cap167mUSD
Jun 16, Last price
6,440.00KRW
1D
-3.16%
1Q
-11.42%
IPO
-76.83%
Name
Jetema Co Ltd
Chart & Performance
P/E
—
P/S
3.37
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
68.52b
+16.70%
Net income
-188m
L
CFO
3.72b
-46.00%
Dividend
Mar 15, 20220.285 KRW/sh
Profile
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company is headquartered in Wonju, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2024‑12 | 2023‑12 | |
| Income | ||
Revenues | 68,520,183 16.70% | 58,716,077 |
Cost of revenue | 53,301,368 | 47,698,825 |
Unusual Expense (Income) | ||
NOPBT | 15,218,815 | 11,017,252 |
NOPBT Margin | 22.21% | 18.76% |
Operating Taxes | (3,068,703) | (12,549,235) |
Tax Rate | ||
NOPAT | 18,287,519 | 23,566,487 |
Net income | (188,253) -101.35% | 13,965,914 |
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | (760,080) | 439,753 |
BB yield | ||
| Debt | ||
Debt current | 117,982,473 | 68,927,478 |
Long-term debt | 1,163,767 | 61,401,271 |
Deferred revenue | 9,734,944 | 9,638,554 |
Other long-term liabilities | 923,801 | 5,305,251 |
Net debt | 88,055,619 | 78,159,902 |
| Cash flow | ||
Cash from operating activities | 3,716,839 | 6,882,677 |
CAPEX | (1,404,884) | (7,210,366) |
Cash from investing activities | (10,572,626) | (8,114,854) |
Cash from financing activities | (17,913,495) | 26,375,397 |
FCF | 12,152,512 | |
| Balance | ||
Cash | 24,046,592 | 46,218,442 |
Long term investments | 7,044,029 | 5,950,404 |
Excess cash | 27,664,612 | 49,233,042 |
Stockholders' equity | (9,526,433) | (5,112,136) |
Invested Capital | 209,993,685 | 213,500,712 |
ROIC | 8.64% | 11.04% |
ROCE | 7.59% | 5.18% |
| EV | ||
Common stock shares outstanding | 35,728 | 19,395 |
Price | ||
Market cap | ||
EV | ||
EBITDA | 24,320,762 | 19,391,331 |
EV/EBITDA | ||
Interest | 12,054,088 | 12,878,500 |
Interest/NOPBT | 79.21% | 116.89% |